No photo of Siobhain Mulrennan

View Scopus Profile

Siobhain Mulrennan

Dr

  • The University of Western Australia (M570), 35 Stirling Highway,

    6009 Perth

    Australia

  • 148 Citations
  • 7 h-Index
20082020
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Siobhain Mulrennan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 38 Similar Profiles
Cystic Fibrosis Medicine & Life Sciences
Spirometry Medicine & Life Sciences
Lung Medicine & Life Sciences
Cough Medicine & Life Sciences
Tricuspid Atresia Medicine & Life Sciences
Health Medicine & Life Sciences
Cohort Effect Medicine & Life Sciences
Azithromycin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

A pragmatic application of endobronchial ultrasound-guided transbronchial needle aspiration: A single institution experience

Bailey, N., Krisnadi, Z., Kaur, R., Mulrennan, S., Phillips, M. & Slavova-Azmanova, N., 20 Aug 2019, In : BMC Pulmonary Medicine. 19, 1, 155.

Research output: Contribution to journal › Article

Open Access
Needles
Non-Small Cell Lung Carcinoma
Sarcoidosis
Documentation
Databases

CLINICAL FEATURES AND LONG-TERM OUTCOME OF PATIENTS WITH SADDLE PULMONARY EMBOLISM: EXPERIENCE FROM TWO TERTIARY CENTRES

Harryanto, H., Ho, A., Solangaarachchi, M., Kuok, Y., Moodley, Y. & Mulrennan, S., Mar 2019, In : Respirology. 24, p. 144-144 1 p.

Research output: Contribution to journal › Abstract/Meeting Abstract

1 Citation (Scopus)

Pregnancy as a risk factor for severe influenza infection: an individual participant data meta-analysis

FLURISK-INVESTIGATORS, 2 Aug 2019, In : BMC Infectious Diseases. 19, 1, 10 p., 683.

Research output: Contribution to journal › Article

Open Access

The significance of anti-granulocyte-macrophage colony-stimulating factor antibodies in cryptococcal infection: case series and review of antibody testing

Stevenson, B., Bundell, C., Mulrennan, S., McLean-Tooke, A., Murray, R. & Brusch, A., 1 Nov 2019, In : Internal Medicine Journal. 49, 11, p. 1446-1450 5 p.

Research output: Contribution to journal › Article

Granulocyte-Macrophage Colony-Stimulating Factor
Cryptococcosis
Antibodies
Infection
Enzyme-Linked Immunosorbent Assay

To be or not to be on CFTR modulators during pregnancy: Risks to be considered

Vekaria, S., Popowicz, N., White, S. W. & Mulrennan, S., 24 Dec 2019, (Accepted/In press) In : Journal of Cystic Fibrosis.

Research output: Contribution to journal › Letter

Projects 2018 2020

A Phase 3, Open-label Study Evaluating the Long-term Safety of VX-445 Combination Therapy in Subjects With Cystic Fibrosis

Mulrennan, S.

Vertex

9/10/19 → 31/12/20

Project: Research

A phase 3b, randomized, double blind, controlled study evaluating the efficacy and safety of VX-445/Tezacaftor/Ivacaftor in Cystic Fibrosis subjects, homozygous for F508del mutation - VX18-445-109

Mulrennan, S.

Vertex

1/10/19 → 31/03/20

Project: Research

A Double Blind Placebo Controlled Multi Centre Clinical Trial to Investigate the Efficacy and Safety of 12 Months of Therapy with Inhaled Colistimethate Sodium in the Treatment of Subjects with Non-Cystic Fibrosis Bronchiectasis

Mulrennan, S.

Covance

1/08/18 → 31/03/20

Project: Research